The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Prescription medicines (75)
- Over the counter (OTC) medicines (12)
- Manufacturing (7)
- Australian Register of Therapeutic Goods (ARTG) (6)
- Complementary medicines (6)
- Non-prescription medicines (6)
- Regulatory compliance (6)
- Safety (6)
- Shortages (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Labelling and packaging (4)
- Therapeutic goods regulation (4)
- Import and export (3)
- Listed medicines (3)
- Scheduling (national classification system) (3)
- Advisory bodies and committees (2)
- Biological medicines (2)
- Legislation (2)
- Medicine safety (2)
- Registered complementary medicines (2)
- Advertising (1)
- Alert/Advisory (1)
- Assessed listed medicines (1)
- Clinical trials (1)
- Electronic submissions (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- TGA conformity assessment certification (1)
Collection content
100 result(s) found, displaying 61 to 70
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
FormsFind out how the free trade agreement affects your application to include a product on the Australian Register of Therapeutic Goods.
-
User guideFind out when you should use a literature-based submissions (LBS) for your application.
-
User guideUser guide on how to submit shortage/discontinuation notifications to the TGA
-
FormsApplication form to import, supply or export a therapeutic good that does not comply with standards.
-
Reference materialGuidance now includes advice on lodgement of provisional variation applications
-
Reference materialGuidance for applicants on how to request and prepare for pre-submission meetings.
-
User guideThis user guide describes how to change sponsor details in the Product Information (PI) and labels for prescription medicines
-
Reference materialGuidance on how to change sponsor details in PI and labels
-
FormsSponsors should note that the Bioequivalence Study Information Form (BSIF) has been amended